Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01008722 · ClinicalTrials.gov registry record
The Dynamics of Human Atrial Fibrillation
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 98
- Enrollment target
NCT01008722: Completed study, sponsored by University of California, San Diego.
NCT01008722 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01008722 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.
Primary Outcome
Using data from cardiac implanted devices when possible, with recurrence defined as 1% recurrence, or data from intermittent 24-72 hour ambulatory ECGs, with recurrence defined as \>30 seconds.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-05 |
What the finished NCT01008722 record still lists
NCT01008722 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01008722 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01008722 about?
NCT01008722 is a clinical study titled "The Dynamics of Human Atrial Fibrillation". The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.
What is the current status of trial NCT01008722?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2009-06. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT01008722?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia